Past Seminar Series Recordings

Cancer Center Seminars are on Tuesdays from 9-10 a.m., 1-125 Cancer and Cardiovascular Research Building.

The following speakers have granted the Masonic Cancer Center permission in advance to record and publish their seminars. For more information, contact Marilyn Lindgard,, 612-625-1405.

Multi-omic approaches for illuminating the 'dark' cancer proteome

February 20, 2018

Timothy Griffin, PhD
Professor & Director, Center for Mass Spectrometry & Proteomics
University of Minnesota

Host: Anja Bielinsky, PhD

Natural Killer Cells Remember

February 6, 2018

Lewis Lanier, PhD
American Cancer Society Professor
Chair, Department of Microbiology and Immunology 

Host: Chris Pennell, PhD

Fueling T Cells in Inflammation and Tumors

January 30, 2018

Jeffrey Rathmell, PhD
Department of Pathology, Microbiology, Immunology
Vanderbilt University Medical Center

Host: Michael Farrar, PhF

Bridging Efficacy and Effectiveness: Knowledge Translation through the Lens of Contemporary Management of Rectal Cancer

January 16, 2018

Deborah Schrag, MD, MPH
Chief, Division of Population Sciences
Department of Medical Oncology Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute

Host: Karen Kuntz, ScD

Nicotine Metabolism, Smoking and Lung cancer: Ethnic/Racial Differences and CYP2A6

January 9, 2018

Sharon Murphy, PhD
Professor Biochemistry, Molecular Biology and Biophysics
University of Minnesota

Host: Lisa Peterson, PhD

Oncolytic Adenovirus: meeting the clinical needs for cancer therapy and imaging

December 19, 2017

Julia Davydova, MD, PhD
Assistant Professor, Department of Surgery
Assistant Professor, Department of Pharmacology
University of Minnesota

Host: Masato Yamamoto, MD, PhD

Brk Function and Therapeutic Targeting in Breast Cancer

December 12, 2017

Amanda Harvey, BSc, PhD, SFHEA
Associate Dean Quality Assurance
Division Lead (Biosciences)
Brunel University London

Host: Carol Lange, PhD

Defining resistance to BRAF inhibition using a novel inducible mouse model of melanoma

November 28, 2017

James Robinson, PhD
Assistant Professor & Section Leader
Cell Signaling & Tumorigenesis
RSRCH Hormel Institute

Host: Carol Lange, PhD

Current and Future Strategies for Cancer Chemoprevention

November 14, 2017

Vernon Steele, PhD
Former Chief Chemopreventive Agent Development Research Group
National Cancer Institute

Host: Frank Ondrey, MD, PhD, FACS

Metabolic reprogramming signatures in kinase inhibitor resistant chronic myeloid leukemia cells.

November 7, 2017

Laurie Parker, PhD

Associate Professor

Dept of Biochemistry, Molecular Biology & Biophysics

University of Minnesota

Host: Lisa Peterson, PhD